Viewing Study NCT05280314

Bugs

Ignite Creation Date: 2025-12-18 @ 9:51 AM

Ignite Modification Date: 2025-12-23 @ 6:59 PM

Study NCT ID: NCT05280314

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module